Brian Wright
Stock Analyst at Roth MKM
(0.46)
# 4,234
Out of 5,143 analysts
31
Total ratings
27.59%
Success rate
-21.99%
Average return
Main Sectors:
Stocks Rated by Brian Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIOX Bioceres Crop Solutions | Maintains: Buy | $20 → $21 | $1.21 | +1,635.54% | 5 | Feb 9, 2024 | |
| ANDE The Andersons | Reiterates: Buy | $65 | $60.25 | +7.88% | 3 | Feb 6, 2024 | |
| BG Bunge Global | Maintains: Buy | $161 → $138 | $112.66 | +22.49% | 2 | Feb 5, 2024 | |
| ADM Archer-Daniels-Midland Company | Downgrades: Neutral | $98 → $66 | $67.12 | -1.67% | 2 | Jan 22, 2024 | |
| FMC FMC Corporation | Initiates: Buy | $74 | $16.02 | +361.92% | 1 | Jan 4, 2024 | |
| CTVA Corteva | Maintains: Buy | $82 → $63 | $71.56 | -11.96% | 2 | Nov 22, 2023 | |
| LNN Lindsay | Upgrades: Buy | $128 → $150 | $126.34 | +18.73% | 3 | Oct 23, 2023 | |
| PAHC Phibro Animal Health | Reiterates: Buy | $21 | $41.61 | -49.53% | 3 | Sep 1, 2023 | |
| UGRO urban-gro | Reiterates: Buy | $11 | $0.19 | +5,845.95% | 2 | Sep 1, 2023 | |
| XXII 22nd Century Group | Reiterates: Buy | $248,400 | $0.83 | +29,927,610.84% | 2 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $60 | $1.04 | +5,697.10% | 3 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $39 | $2.22 | +1,656.76% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $297 | $446.57 | -33.49% | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.00 | +11,900.00% | 1 | Oct 8, 2021 |
Bioceres Crop Solutions
Feb 9, 2024
Maintains: Buy
Price Target: $20 → $21
Current: $1.21
Upside: +1,635.54%
The Andersons
Feb 6, 2024
Reiterates: Buy
Price Target: $65
Current: $60.25
Upside: +7.88%
Bunge Global
Feb 5, 2024
Maintains: Buy
Price Target: $161 → $138
Current: $112.66
Upside: +22.49%
Archer-Daniels-Midland Company
Jan 22, 2024
Downgrades: Neutral
Price Target: $98 → $66
Current: $67.12
Upside: -1.67%
FMC Corporation
Jan 4, 2024
Initiates: Buy
Price Target: $74
Current: $16.02
Upside: +361.92%
Corteva
Nov 22, 2023
Maintains: Buy
Price Target: $82 → $63
Current: $71.56
Upside: -11.96%
Lindsay
Oct 23, 2023
Upgrades: Buy
Price Target: $128 → $150
Current: $126.34
Upside: +18.73%
Phibro Animal Health
Sep 1, 2023
Reiterates: Buy
Price Target: $21
Current: $41.61
Upside: -49.53%
urban-gro
Sep 1, 2023
Reiterates: Buy
Price Target: $11
Current: $0.19
Upside: +5,845.95%
22nd Century Group
Aug 23, 2023
Reiterates: Buy
Price Target: $248,400
Current: $0.83
Upside: +29,927,610.84%
Jul 21, 2023
Maintains: Buy
Price Target: $10 → $60
Current: $1.04
Upside: +5,697.10%
Apr 3, 2023
Maintains: Buy
Price Target: $78 → $39
Current: $2.22
Upside: +1,656.76%
Jun 3, 2022
Initiates: Buy
Price Target: $297
Current: $446.57
Upside: -33.49%
Oct 8, 2021
Initiates: Buy
Price Target: $120
Current: $1.00
Upside: +11,900.00%